Carcinomas of the Head and Neck

Evaluation and Management

Nonfiction, Health & Well Being, Medical, Specialties, Oncology, Surgery
Cover of the book Carcinomas of the Head and Neck by , Springer US
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781461314998
Publisher: Springer US Publication: December 6, 2012
Imprint: Springer Language: English
Author:
ISBN: 9781461314998
Publisher: Springer US
Publication: December 6, 2012
Imprint: Springer
Language: English

It was not too many years ago that the role of chemotherapy for head and neck cancer consisted of single-agent methotrexate for selected patients with recurrent disease. In the past decade, multiple new agents, high-dose chemotherapy, combinations, and intra-arterial approaches have been used for the patient with recurrent disease. Wheeler critically assesses the current status of these approaches. When oncologists began testing chemotherapy in the combined modality approach, trials consisted of induction chemotherapy and use of single agents as radiosensitizers. Although a great deal has been learned from these trials, benefit in terms of survival has been marginal. Even more promising may be the concomitant use of combination chemo­ therapy and radiation. Taylor describes the encouraging results as well as the potential. Induction chemotherapy may have a second important goal in addition to improving curability-it could be used for organ preservation. Dimery et al., present the background for this approach in the patient with laryngeal cancer as well as a description of their randomized trial for voice preservation. Head and neck squamous cancers are a heterogeneous group of diseases, and surgeons have long sought parameters that will help predict outcome.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

It was not too many years ago that the role of chemotherapy for head and neck cancer consisted of single-agent methotrexate for selected patients with recurrent disease. In the past decade, multiple new agents, high-dose chemotherapy, combinations, and intra-arterial approaches have been used for the patient with recurrent disease. Wheeler critically assesses the current status of these approaches. When oncologists began testing chemotherapy in the combined modality approach, trials consisted of induction chemotherapy and use of single agents as radiosensitizers. Although a great deal has been learned from these trials, benefit in terms of survival has been marginal. Even more promising may be the concomitant use of combination chemo­ therapy and radiation. Taylor describes the encouraging results as well as the potential. Induction chemotherapy may have a second important goal in addition to improving curability-it could be used for organ preservation. Dimery et al., present the background for this approach in the patient with laryngeal cancer as well as a description of their randomized trial for voice preservation. Head and neck squamous cancers are a heterogeneous group of diseases, and surgeons have long sought parameters that will help predict outcome.

More books from Springer US

Cover of the book Oral Mucosal Drug Delivery and Therapy by
Cover of the book The Token Economy by
Cover of the book Prehistoric Iberia by
Cover of the book Late Effects of Treatment for Brain Tumors by
Cover of the book Biomedical Scientists and Public Policy by
Cover of the book Instruction Level Parallelism by
Cover of the book Handbook of Mental Illness in the Mentally Retarded by
Cover of the book Agricultural Cooperatives by
Cover of the book Critical Reviews in Tropical Medicine by
Cover of the book Rethinking Depression by
Cover of the book Dyslexia by
Cover of the book The Determinants of Economic Growth by
Cover of the book Understanding Natural Flavors by
Cover of the book Composite Sampling by
Cover of the book The Mental Health Consequences of Torture by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy